Covaxin: An overview of its immunogenicity and safety trials in India.

Sharma, Rohit; Tiwari, Swati; Dixit, Aparna

Sharma, Rohit; Tiwari, Swati; Dixit, Aparna.

Afiliação

Sharma R; School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.
Tiwari S; School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.
Dixit A; School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.

Bioinformation ; 17(10): 840-845, 2021.

Article em En | MEDLINE | ID: mdl-35574502

Palavras-chave

BBV152; COVID-19; Covaxin; SARS-CoV-2 vaccine variants; animal and human trial

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070630
https://dx.doi.org/10.6026/97320630017840

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070630
https://dx.doi.org/10.6026/97320630017840

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article